학술논문
Faster-acting insulin aspart versus insulin aspart in the treatment of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology November 2023 11(11):811-821
Subject
Language
ISSN
2213-8587